Clinical and molecular characterization of patients with cancer of unknown primary in the modern era-Reference-Cited by-同舟云学术

Clinical and molecular characterization of patients with cancer of unknown primary in the modern era

Published:2017-12 Issue:12 Volume:28 Page:3015-3021
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Varghese A.M.,Arora A.,Capanu M.,Camacho N.,Won H.H.,Zehir A.,Gao J.,Chakravarty D.,Schultz N.,Klimstra D.S.,Ladanyi M.,Hyman D.M.,Solit D.B.,Berger M.F.,Saltz L.B.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/12/3015/24169178/mdx545.pdf

Reference27 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Network NCC. NCCN Guidelines: Occult Primary Version 2.2016. http://www.nccn.org (2 October 2017, date last accessed).

3. Cancer of unknown primary site;Varadhachary;N Engl J Med,2014

4. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction;Greco;Oncologist,2010

5. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary;Tothill;J Pathol,2013

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study;The Lancet;2024-08

2. Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer;Current Issues in Molecular Biology;2024-07-09

3. The evolution of molecular management of carcinoma of unknown primary;Current Opinion in Oncology;2024-06-17

4. Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition;Anti-Cancer Drugs;2024-04-29

5. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology;The Oncologist;2024-03-23